For: | Porrata LF, Markovic SN. Autograft mediated adoptive immunotherapy of cancer in the context of autologous stem cell transplantation. World J Clin Oncol 2010; 1(1): 29-34 [PMID: 21603308 DOI: 10.5306/wjco.v1.i1.29] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v1/i1/29.htm |
Number | Citing Articles |
1 |
Craig S. Sauter, Sergio Giralt. The prognostic impact of peripheral blood progenitor cell dose following high-dose therapy and autologous stem cell transplant for hematologic malignancies. Leukemia & Lymphoma 2015; 56(6): 1619 doi: 10.3109/10428194.2014.970544
|
2 |
Yundeok Kim, Soo‐Jeong Kim, June‐Won Cheong, Hyunsoo Cho, Haerim Chung, Jung Yeon Lee, Ji Eun Jang, Yoo Hong Min, Jin Seok Kim. Clinical impact of early recovery of peripheral blood absolute lymphocyte count after frontline autologous stem cell transplantation for diffuse large B‐cell lymphoma. Hematological Oncology 2017; 35(4): 465 doi: 10.1002/hon.2332
|
3 |
D Dunn, P Vikas, M Jagasia, B N Savani. Plerixafor in AL amyloidosis: improved graft composition and faster lymphocyte recovery after auto-SCT in patient with end-stage renal-disease. Bone Marrow Transplantation 2012; 47(8): 1136 doi: 10.1038/bmt.2011.226
|
4 |
Anu Partanen, Antti Turunen, Outi Kuittinen, Hanne Kuitunen, Pentti Mäntymaa, Ville Varmavuo, Esa Jantunen. Predictive Factors for Early Immune Recovery in NHL Patients after Autologous Transplantation: A Multicenter Prospective Study. Cancers 2024; 16(14): 2550 doi: 10.3390/cancers16142550
|
5 |
O. K. Idowu, Q. Ding, A. F. G. Taktak, C. R. Chandrasekar, Q. Yin. Clinical implication of pretreatment neutrophil to lymphocyte ratio in soft tissue sarcoma. Biomarkers 2012; 17(6): 539 doi: 10.3109/1354750X.2012.699554
|
6 |
Luis F. Porrata. Autologous Graft-versus-Tumor Effect: Reality or Fiction?. Advances in Hematology 2016; 2016: 1 doi: 10.1155/2016/5385972
|
7 |
Esa Jantunen, Ville Varmavuo, Jukka Pelkonen, Jaakko Valtola. Importance of early immune recovery after autologous hematopoietic cell transplantation in lymphoma patients. Leukemia & Lymphoma 2019; 60(9): 2115 doi: 10.1080/10428194.2019.1581929
|
8 |
Bipin N. Savani. Can we modify transplant outcome by improving lymphocyte recovery?. Cytotherapy 2011; 13(8): 900 doi: 10.3109/14653249.2011.603220
|
9 |
A Kansagra, D J Inwards, S M Ansell, I N Micallef, P B Johnston, W J Hogan, S N Markovic, L F Porrata. Infusion of autograft natural killer cell/CD14+HLA-DRDIM cell ratio predicts survival in lymphoma post autologous stem cell transplantation. Bone Marrow Transplantation 2018; 53(2): 146 doi: 10.1038/bmt.2017.225
|
10 |
Egor V. Batorov, Ekaterina Ya. Shevela, Marina A. Tikhonova, Dariya S. Batorova, Galina Yu. Ushakova, Svetlana A. Sizikova, Vera V. Sergeevicheva, Andrey V. Gilevich, Irina V. Kryuchkova, Alexandr A. Ostanin, Elena R. Chernykh. Mesenchymal stromal cells improve early lymphocyte recovery and T cell reconstitution after autologous hematopoietic stem cell transplantation in patients with malignant lymphomas. Cellular Immunology 2015; 297(2): 80 doi: 10.1016/j.cellimm.2015.07.001
|